AddLife Logo

AddLife

ISIN: SE0014401378 | Ticker: ALIF | LEI: 5493005T3M7CD7XWE013
Sector: Health CareSub-Industry: Health Care Technology
Country: Sweden

About AddLife

Company Description

AddLife is a Swedish Medtech company active on the European market. AddLife owns and acquires companies in niche segments with offerings aimed primarily at the healthcare sector, from research to medical care.

The head office is located in Stockholm.

Year founded

2016

Served area

Worldwide

Headquarters

Brunkebergstorg 5, 10362 Stockholm – Sweden

Financial statements

Download as Excel
Line item in (sek) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A 4,149,600,000.00 10,596,000,000.00 13,057,000,000.00
Noncurrent Assets N/A 2,457,200,000.00 7,845,000,000.00 9,485,000,000.00
Property Plant And Equipment N/A 433,600,000.00 627,000,000.00 899,000,000.00
Noncurrent Receivables N/A 7,000,000.00 7,000,000.00 85,000,000.00
Deferred Tax Assets N/A 5,000,000.00 11,000,000.00 51,000,000.00
Other Noncurrent Financial Assets N/A 8,800,000.00 9,000,000.00 10,000,000.00
Current Assets N/A 1,692,400,000.00 2,751,000,000.00 3,572,000,000.00
Inventories N/A 640,200,000.00 1,189,000,000.00 1,646,000,000.00
Current Tax Assets Current N/A 300,000.00 24,000,000.00 78,000,000.00
Cash and cash equivalents 99,100,000.00 216,000,000.00 345,000,000.00 376,000,000.00
Equity And Liabilities N/A 4,149,600,000.00 10,596,000,000.00 13,057,000,000.00
Equity 1,476,200,000.00 1,889,000,000.00 4,291,000,000.00 4,971,000,000.00
Issued Capital N/A 58,300,000.00 62,000,000.00 62,000,000.00
Retained Earnings N/A 739,000,000.00 1,547,000,000.00 1,787,000,000.00
Share Premium N/A 1,134,300,000.00 2,654,000,000.00 2,642,000,000.00
Other Reserves N/A -49,500,000.00 22,000,000.00 477,000,000.00
Equity Attributable To Owners Of Parent N/A 1,882,100,000.00 4,285,000,000.00 4,968,000,000.00
Noncontrolling Interests N/A 8,200,000.00 6,000,000.00 3,000,000.00
Liabilities N/A 2,259,300,000.00 6,305,000,000.00 8,086,000,000.00
Noncurrent Liabilities N/A 514,300,000.00 1,393,000,000.00 3,630,000,000.00
Noncurrent Provisions N/A 29,500,000.00 32,000,000.00 134,000,000.00
Noncurrent Provisions For Employee Benefits N/A 80,500,000.00 82,000,000.00 60,000,000.00
Deferred Tax Liabilities N/A 161,500,000.00 489,000,000.00 459,000,000.00
Other Noncurrent Financial Liabilities N/A 99,600,000.00 564,000,000.00 2,744,000,000.00
Other Noncurrent Liabilities N/A 1,200,000.00 2,000,000.00 8,000,000.00
Current Liabilities N/A 1,745,000,000.00 4,912,000,000.00 4,456,000,000.00
Current Provisions N/A 9,400,000.00 10,000,000.00 52,000,000.00
Trade And Other Current Payables To Trade Suppliers N/A 648,800,000.00 796,000,000.00 957,000,000.00
Current Tax Liabilities Current N/A 81,100,000.00 110,000,000.00 70,000,000.00
Other Current Financial Liabilities N/A 473,000,000.00 3,194,000,000.00 2,491,000,000.00
Other Current Liabilities N/A 231,400,000.00 301,000,000.00 268,000,000.00
Line item in (sek) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 5,273,300,000.00 7,993,000,000.00 9,084,000,000.00
Other Income 84,300,000.00 100,000,000.00 218,000,000.00
Profit Loss From Operating Activities 672,500,000.00 996,000,000.00 808,000,000.00
Finance Income 700,000.00 97,000,000.00 445,000,000.00
Finance Costs 14,200,000.00 166,000,000.00 651,000,000.00
Profit Loss Before Tax 659,000,000.00 927,000,000.00 602,000,000.00
Income Tax Expense Continuing Operations 139,300,000.00 206,000,000.00 119,000,000.00
Profit (loss) 519,700,000.00 721,000,000.00 483,000,000.00
Profit Loss Attributable To Owners Of Parent 517,800,000.00 719,000,000.00 480,000,000.00
Profit Loss Attributable To Noncontrolling Interests 1,900,000.00 2,000,000.00 3,000,000.00
Line item in (sek) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A 519,700,000.00 721,000,000.00 483,000,000.00
Adjustments For Decrease Increase In Inventories N/A -119,100,000.00 53,000,000.00 -88,000,000.00
Adjustments For Decrease Increase In Other Operating Receivables N/A -170,600,000.00 18,000,000.00 64,000,000.00
Adjustments For Increase Decrease In Other Operating Payables N/A 397,400,000.00 -185,000,000.00 -97,000,000.00
Other Adjustments For Noncash Items N/A 280,400,000.00 449,000,000.00 684,000,000.00
Income Taxes Paid Refund Classified As Operating Activities N/A 97,000,000.00 252,000,000.00 256,000,000.00
Cash Flows From Used In Operating Activities N/A 950,100,000.00 1,010,000,000.00 909,000,000.00
Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 0.00 0.00 0.00
Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities N/A 345,100,000.00 2,843,000,000.00 818,000,000.00
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities N/A 7,800,000.00 9,000,000.00 13,000,000.00
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 62,700,000.00 101,000,000.00 213,000,000.00
Proceeds From Sales Of Intangible Assets Classified As Investing Activities N/A 800,000.00 0.00 1,000,000.00
Purchase Of Intangible Assets Classified As Investing Activities N/A 29,500,000.00 42,000,000.00 69,000,000.00
Cash Flows From Used In Investing Activities N/A -428,700,000.00 -2,977,000,000.00 -1,086,000,000.00
Payments To Acquire Or Redeem Entitys Shares N/A 19,300,000.00 0.00 60,000,000.00
Proceeds From Borrowings Classified As Financing Activities N/A 265,200,000.00 2,649,000,000.00 1,416,000,000.00
Repayments Of Borrowings Classified As Financing Activities N/A 614,400,000.00 260,000,000.00 846,000,000.00
Other Inflows Outflows Of Cash Classified As Financing Activities N/A -3,300,000.00 -121,000,000.00 -160,000,000.00
Cash Flows From Used In Financing Activities N/A -372,500,000.00 2,070,000,000.00 134,000,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A 148,900,000.00 103,000,000.00 -43,000,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A -32,000,000.00 26,000,000.00 74,000,000.00
Cash and cash equivalents 99,100,000.00 216,000,000.00 345,000,000.00 376,000,000.00

Please note that some sums might not add up.

Filings & Publications

2022

Report
Q1
H1
Q3
FY
Consolidated Report
SWE
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2021

Report
Q1
H1
Q3
FY
Consolidated Report
SWE
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
20.02.24 Christina Rubenhag Other Buy SEK 51,400.00
21.12.23 Håkan Roos Other Buy SEK 521,431.75
24.11.23 Fredrik Dalborg Other Buy SEK 89,950.00
23.11.23 Anna Isoz Dalborg Other Buy SEK 49,911.40
02.11.23 Märta Isoz Dalborg Other Buy SEK 1,540.35
25.09.23 Håkan Roos Other Buy SEK 290,970.00
18.09.23 Fredrik Dalborg Other Buy SEK 207,990.00
12.05.23 Fredrik Dalborg Other Buy SEK 129,400.00
24.03.23 Fredrik Dalborg Other Buy SEK 139,200.00
24.03.23 Christina Rubenhag Other Buy SEK 100,160.30

Capital markets information

ISIN

SE0014401378

LEI

5493005T3M7CD7XWE013

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Technology

Sub-Industry

Health Care Technology

Listed Stock Exchange

Nasdaq Stockholm

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.